Small Cap Watch: These 4 Stocks Are Making Big Moves Today

NEW YORK, NY / ACCESSWIRE / April 27, 2016 / The Stock Expert is issuing a report on four stocks that are performing well this Tuesday. SRPT, LGCY, ORIG and AMRS are on high volume alert. Continue reading to find out why. – To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.

Legacy Reserves LP (NASDAQ: LGCY) The company acquires and develops oil and natural gas properties primarily in the Permian Basin, East Texas, Rocky Mountain, and Mid-Continent regions of the United States.

When we first alerted you on LGCY, the stock has been one of the hottest stocks on the Nasdaq in April, tripling its share price in just 1 months, rarely with a down day.

LGCY is continuing this trend even higher today, up over 17% off heavier than usual volume. For the past 4 trading periods, LGCY has been the recipient of an influx of volume, however, with an RSI (relative strength index) of 86.70, the stock may need a little time to cool off before going higher.

Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.

Ocean Rig UDW Inc. (NASDAQ: ORIG) Is an offshore drilling contractor, which provides oilfield services for offshore oil and gas exploration, development, and production drilling worldwide.

Like LGCY, ORIG has been one of the hottest stocks on the Nasdaq this month, trading higher by about 100% in April, with very few down days.

The stock is also getting a boost after announcing the acquisition of Ultra Deepwater Drillship just two days ago. – ORIG and LGCY have a lot of momentum moving into next month.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Is an agricultural biotechnology company that engages in crop seed breeding and genetic improvement activities in the Peoples Republic of China.

Shares of SRPT are trading lower today by off heavier than usual volume this morning after an FDA advisory panel has recommended against approving Sarepta Therapeutics’ promising drug for DMD.

SRPT hit its 52 week low after the news yesterday after a massive selloff occurred and today appears to be a continuation of the trend.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

Amyris, Inc. (NASDAQ: AMRS) The Company provides various alternatives to a range of petroleum-sourced products worldwide.

Shares of AMRS are trading higher today by over 20% after announcing the execution of their five year Biofene supply agreement with a global nutraceuticals company, expects total revenue from the agreement to be more than $100 million.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About TheStockExpert.com

The Stock Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “STOCKEXPERT”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The Stock Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The Stock Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit TheStockExpert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The Stock Expert
info@thestockexpert.com

SOURCE: The Stock Expert

ReleaseID: 439281